Why is Aarti Pharma falling/rising?

As of 28-Jul, Aarti Pharmalabs Ltd is experiencing a decline in its stock price, currently at Rs 922.40, which reflects a decrease of Rs 17.65 or 1.88%. Today's price summary indicates that the stock has underperformed its sector by 1.96%, with an intraday low of Rs 918.55. The stock's performance over the past week shows a decline of 2.71%, while it has performed positively over the past month with a return of 7.35%. Despite strong financial metrics such as a low Debt to EBITDA ratio and impressive growth in net sales and profits, the stock faces challenges, including poor long-term growth rates and a decrease in promoter confidence, as evidenced by a 0.57% reduction in their stake.
Broader market context reveals that while Aarti Pharmalabs has generated a remarkable return of 53.25% over the past year, the benchmark index, Sensex, has seen a slight decline of 0.54%. In the short term, the stock's performance has lagged behind the benchmark, which has decreased by 1.59% over the past week. This underperformance, coupled with falling investor participation and liquidity concerns, may contribute to the stock's current downward movement, despite its strong historical performance and attractive valuation compared to peers.